| Series Introduction (Lester Packer and Enrique Cadenas) |
|
iii | |
| Preface |
|
vii | |
| Contributors |
|
xiii | |
| I. General Topics |
|
|
Food-Derived Antioxidants: How to Evaluate Their Importance in Food and In Vivo |
|
|
1 | (46) |
|
|
|
|
|
|
Measurement of Total Antioxidant Capacity in Nutritional and Clinical Studies |
|
|
47 | (10) |
|
|
|
|
|
|
|
|
|
|
|
Quantification of Isoprostanes as Indicators of Oxidant Stress In Vivo |
|
|
57 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| II. Vitamin E |
|
|
Efficacy of Vitamin E in Human Health and Disease |
|
|
75 | (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vitamin E Bioavailability, Biokinetics and Metabolism |
|
|
99 | (10) |
|
|
|
|
|
|
Biological Activity of Tocotrienols |
|
|
109 | (8) |
|
|
|
|
|
|
|
|
|
|
| III. Vitamin C |
|
|
Vitamin C: From Molecular Actions to Optimum Intake |
|
|
117 | (30) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vitamin C and Cardiovascular Diseases |
|
|
147 | (20) |
|
|
|
|
|
|
|
|
|
|
|
Epidemiological and Clinical Aspects of Ascorbate and Cancer |
|
|
167 | (22) |
|
|
|
|
|
| IV. Carotenoids |
|
|
Carotenoids: Linking Chemistry, Absorption and Metabolism to Potential Roles in Human Health and Disease |
|
|
189 | (34) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antioxidant Effects of Carotenoids: Implication in Photoprotection in Humans |
|
|
223 | (12) |
|
|
|
|
|
|
|
|
|
|
|
Oxidative Breakdown of Carotenoids and Biological Effects of Their Metabolites |
|
|
235 | (16) |
|
|
|
|
|
|
|
|
|
|
|
Frederik J. G. M. van Kuijk |
|
|
|
|
|
Carotenoids in the Nutrition of Infants |
|
|
251 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Human Studies on Bioavailability and Serum Response of Carotenoids |
|
|
265 | (14) |
|
|
|
|
|
| V. Polyphenols and Flavonoids |
|
|
Caffeic Acid and Related Antioxidant Compounds: Biochemical and Cellular Effects |
|
|
279 | (24) |
|
|
|
|
|
|
Polyphenols and Flavonoids Protect LDL Against Atherogenic Modifications |
|
|
303 | (34) |
|
|
|
|
|
|
|
|
|
|
|
Phytoestrogen Content in Foods and Their Role in Cancer |
|
|
337 | (14) |
|
|
|
|
|
|
|
|
|
|
|
Peroxynitrite Scavenging by Mitochondrial Reductants and Plant Polyphenols |
|
|
351 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VI. Antioxidants in Beverages and Herbal Products |
|
|
Antioxidant and Other Properties of Green and Black Tea |
|
|
371 | (30) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul T. Quinlan, Ute M. Weisgerber |
|
|
|
|
|
|
|
|
|
|
The Phenolic Wine Antioxidants |
|
|
401 | (16) |
|
|
|
|
|
|
French Maritime Pine Bark: Pycnogenol |
|
|
417 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spices as Potent Antioxidants with Therapeutic Potential |
|
|
437 | (36) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VII. Lipoic Acid and Glutathione |
|
|
Lipoic Acid: Cellular Metabolism, Antioxidant Activity and Clinical Relevance |
|
|
473 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cellular Effects of Lipoic Acid and Its Role in Aging |
|
|
489 | (22) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vascular Complications in Diabetes: Mechanisms and the Influence of Antioxidants |
|
|
511 | (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Therapeutic Effects of Lipoic Acid on Hyperglycemia and Insulin Resistance |
|
|
535 | (14) |
|
|
|
|
|
|
Bioavailability of Glutathione |
|
|
549 | (16) |
|
|
|
|
|
| VIII. Melatonin |
|
|
Antioxidant Capacity of Melatonin |
|
|
565 | (50) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Radical and Reactive Intermediate-Scavenging Properties of Melatonin in Pure Chemical Systems |
|
|
615 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IX. Selenium |
|
|
Selenium: An Antioxidant? |
|
|
633 | (32) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selenium Status and Prevention of Chronic Diseases |
|
|
665 | (24) |
|
|
|
|
|
| X. Nitric Oxide |
|
|
Antioxidant Properties of Nitric Oxide |
|
|
689 | (18) |
|
|
|
|
|
|
|
|
|
|
| Index |
|
707 | |